logo
logo

Medrhythms Closes $25M Series B Funding Led By Morningside Ventures And Advantage Capital To Advance Digital Therapeutics Platform

Jul 28, 2021•almost 4 years ago

Amount Raised

$25 Million

Round Type

series b

Portland

Description

MedRhythms, a leader in developing prescription digital therapeutics that use sensors, software, and music to measure and improve walking for patients with a neurologic injury or disease, announced today the closing of a $25 million Series B financing round co-led by Morningside Ventures and Advantage Capital, with participation from existing investor Werth Family Investment Associates. The Company has raised a total of $34 million in gross proceeds from private financings since inception.

Company Information

Company

Med Rhythms

Location

Portland, Oregon, United States

About

MedRhythms is a digital therapeutics company that uses sensors, music and software to build evidence-based neurologic interventions to measure and improve walking. The Company’s product pipeline consists of multiple clinical programs for neurologic conditions, the most advanced are in chronic stroke, multiple sclerosis, and Parkinson’s disease. MedRhythms was founded out of Spaulding Rehabilitation Hospital, one of the leading rehabilitation hospitals in the United States. MedRhythms is headquartered in Portland, Maine. For more information, please visit www.medrhythms.com.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech